NantBioscience, Inc. logo

NantBioscience, Inc.

NantBioscience, Inc. develops molecularly targeted drugs based on the profile of the patient's tumor and drugs that remediate the activities of the often mutated tumor suppressor, p53. It develops a pipeline of nab-based molecules, and inh

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://nanovelos.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
9920 Jefferson Boulevard,California 90232
Culver City
United States
Email
Contact Number
+1 310-853-7888

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/nantbioscience” connections=”true” suffix=””]